Stephen Cornelissen on 20th Strategic Blood Forum from Australian Red Cross Lifeblood
Stephen Cornelissen, CEO of Australian Red Cross Lifeblood, shared on LinkedIn:
”It was wonderful to come together this week with global and local experts from government, clinical practice, industry, and the community for the 20th Strategic Blood Forum, hosted by Australian Red Cross Lifeblood.
The Forum provided a valuable opportunity to share knowledge and explore global trends in blood product supply, demand, policy, and innovation and consider their relevance to Australia. At Lifeblood, we are committed to driving meaningful change for the health and wellbeing of Australians today, tomorrow and well into the future.
A special thank you to our ambassador Michael Klim for sharing his insights as a recipient of the plasma derived product IVIg, along with his partner Michelle who also presented.
Demand is growing for this product, and we are grateful for all our plasma donors.”
Stay updated with Hemostasis Today.
-
Apr 23, 2026, 02:17Francisco Chacón-Lozsán: Pulmonary Artery Catheter in Cardiogenic Shock From Obsolete Device to Modern Decision Tool
-
Apr 23, 2026, 01:33Maha Othman: Our Research Group Had a Highly Successful Showing at the ISLH 2026 Congress
-
Apr 22, 2026, 17:19Ralf Ludwig: Bridging Population Data and Immunology in Inflammatory Diseases
-
Apr 22, 2026, 17:15Giacomo Rossi: Genetic Study Reveals 10 Genes in Hyperemesis Gravidarum
-
Apr 22, 2026, 17:06Maura Boerio: Quantifying Barriers to Care in Vascular Ehlers-Danlos Syndrome
-
Apr 22, 2026, 17:05Kausik Ray։ Metabolically Healthy Obesity Is Being Re-Evaluated as a High-Risk Condition Needing Closer Attention
-
Apr 22, 2026, 16:58Baba-Jallah Epega: Sickle Cell Resilience Through Patient Voices and Clinical Insight
-
Apr 22, 2026, 16:44Francisco Chacón-Lozsán: Cytokine Storm Is Not Just Inflammation, It Is Organ Failure in Motion
-
Apr 22, 2026, 16:29CBTH 2026 Opens with First Workshop in Germany – European Hematology Association